5 June 2024

cardiovascular Diabetes Obesity

Semaglutide reduces CV events, with or without weight loss

3 June 2024

Diabetes PBS Political

PBS rejigs rules on GLP-1s and other diabetes meds

30 May 2024

Cardiovascular Diabetes Women

Men have more diabetes complications than women

22 May 2024

Diabetes Obesity Pharmacy Political

Ozempic compounded in ‘disgusting’ conditions

22 May 2024

Diabetes Obesity Political TheHill

Butler slaps ban on compounded semaglutide and tirzepatide

20 May 2024

Diabetes Insurance Political

Health fund wobbles on weight-loss coverage

29 April 2024

Cardio Cardiology Diabetes Pharmaceuticals

SGLT2s cut cardiac risk for most with T2D

5 April 2024

Comment Diabetes Policy

Australia has fallen behind in our response to diabetes

4 April 2024

Clinical Diabetes

Practical guide to tirzepatide

3 April 2024

Clinical Diabetes

Coming up: Prevention and management of diabetic retinopathy

2 April 2024

Diabetes Political

Mystery of the red Ozempic deepens

25 March 2024

Clinical Diabetes Endocrinology

Coming up: Practical Guide to Tirzepatide

22 March 2024

Diabetes Political

GLP-1 agonist pharma execs slam PBAC’s snail-paced process

22 March 2024

Clinical Diabetes Endocrinology

Finerenone for chronic kidney disease in type 2 diabetes

6 March 2024

Diabetes Political RACGP

Guild reignites push for pharmacy diabetes screening

1 March 2024

Diabetes Obesity Political

TGA moots crackdown on semaglutide compounding